Stay updated on Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check8 days agoChange DetectedThe web page now includes a service alert regarding planned maintenance starting July 25th, indicating that most services will be unavailable for over 24 hours beginning at 9 PM EDT.SummaryDifference0.6%
- Check15 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.7%
- Check22 days agoChange DetectedThe web page has updated key survival metrics and timelines related to a study, including the definitions of Overall Survival (OS) and Progression-free Survival (PFS) at two years, while removing previous definitions and estimates for these metrics.SummaryDifference6%
- Check30 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial page.